COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 55: Articles 541-550  | Next

Retrospective evaluation of school-related measures on pre-vaccination transmission dynamics of SARS-CoV-2
Canfora, B., Escosio, R. A., van Dorp, C. H., Boldea, O., Bonten, M., Nunes, A., Rozhnova, G.
10.1101/2025.04.14.25325720 — Posted: 2025-04-16
Contributions of Genetic Liability and the COVID-19 Pandemic to Rising Psychopathology Among Youth in the United States
Shao, L., Ahern, J., Loughnan, R., Xu, B., Baker, H. E., Tapert, S. F., Baker, F. C., Thompson, W. K., Kiss, O., Muller-Oehring, E. M., Gombert-Labedens, M., Fan, C. C.
10.1101/2025.04.14.25325727 — Posted: 2025-04-16
COVID-19 Pandemic-related differences in the prevalence of genetic conditions and healthcare utilization and access for children with genetic conditions the United States.
Thakral, A., Moorthy, D., Tandon, T., Viswanathan, K., Kupferman, F.
10.1101/2025.04.14.25325831 — Posted: 2025-04-16
Mapping Structural Barriers: A Geospatial Assessment of COVID-19 Vaccine Inequities in Kenya
Nino, L., Kiragga, A., Miller, F. D., Mwalili, S., Musuka, G., Cuadros, D. F.
10.1101/2025.04.14.25325797 — Posted: 2025-04-16
Estimating the effectiveness of non-pharmaceutical interventions against COVID-19 transmission in the Netherlands
Backer, J. A., Klinkenberg, D., Miura, F., Wallinga, J.
10.1101/2025.04.14.25325804 — Posted: 2025-04-16
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
Samandari, T., Achola, M., Hutter, J. N., Mboya, G., Otieno, W., Kee, J. J., Huang, Y., Aponte, J. J., Ockenhouse, C. F., Lee, C. K., Polakowski, L. L. K., Yacovone, M., Tapley, A., Dadabhai, S., Mkhize, N. N., Kaldine, H., Bhebhe, S., Moore, P., Hural, J., Garrett, N., Kublin, J.
10.1101/2025.04.12.25325718 — Posted: 2025-04-16
COVID-19 and Influenza vaccine co-administration, and missed opportunities to increase COVID-19 vaccination coverage among U.S. adults, 2023-2024
Qasmieh, S. A., Penrose, K., Robertson, M. M., Piltch-Loeb, R., Rane, M. S., Nash, D.
10.1101/2025.04.14.25325480 — Posted: 2025-04-16
STUDY OF FACTORS ASSOCIATED WITH PSYCHOSOCIAL WELL-BEING DURING THE COVID-19 PANDEMIC IN SENEGAL
KASSE, F., Tine, J. A., Faye, A., Gaye, I., Diallo, A. I., Ridde, V.
10.1101/2025.04.15.25325869 — Posted: 2025-04-16
Deletion detection in SARS-CoV-2 genomes using multiplex-PCR sequencing from COVID-19 patients: elimination of false positives
Jiang, N., Dewey, C. N., Yin, J.
10.1101/2025.04.15.25325794 — Posted: 2025-04-16
Characterization and evolutionary history of novel SARS-CoV-2-related viruses in bats from Cambodia
Ou, T. P., Guillebaud, J., Baidaliuk, A., Tum, S., Chheang, D., Delaune, D., Prot, M., Rahal Guaragna Machado, R., Pum, L., Hul, V., Hoem, T., Ly, S., Auerswald, H., Smith, G. J., Dussart, P., Karlsson, E. A., Chevalier, V., Cappelle, J., Duong, V., Simon-Loriere, E.
10.1101/2025.04.15.648942 — Posted: 2025-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).